Priming with recombinant human hematopoietic cytokines before bone marrow harvest expands in vivo and enhances ex vivo recovery of myeloid progenitors in short-term liquid cultures. [electronic resource]
Producer: 19940217Description: 80-6 p. digitalISSN:- 0301-472X
- Antigens, CD -- analysis
- Antigens, CD34
- Bone Marrow -- drug effects
- Cell Division -- physiology
- Cytokines -- pharmacology
- Dose-Response Relationship, Drug
- Erythropoietin -- pharmacology
- Granulocyte Colony-Stimulating Factor -- pharmacology
- Granulocyte-Macrophage Colony-Stimulating Factor -- pharmacology
- Hematopoietic Stem Cells -- drug effects
- Humans
- Interleukin-3 -- pharmacology
- Leukemia -- pathology
- Recombinant Proteins -- pharmacology
- Time Factors
- Tumor Cells, Cultured -- drug effects
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.